We are live on ! Find out more
SM

Sabby Management Portfolio holdings

AUM $45.1M
1-Year Est. Return 74.25%
This Fund
S&P 500
This Quarter Est. Return
-34.3%
1 Year Est. Return
-74.25%
3 Year Est. Return
-95.86%
5 Year Est. Return
-99.36%
10 Year Est. Return
-99.46%
AUM
$115M
AUM Growth
+$792K
Cap. Flow
+$6.43M
Cap. Flow %
5.6%
Top 10 Hldgs %
83.12%
Holding
142
New
32
Increased
15
Reduced
32
Closed
53

Top Buys

Rank Stock Value
1
RCON icon
Recon Technology
RCON
+$5M
2
GMVD
G Medical Innovations Holdings Ltd. Ordinary Shares
GMVD
+$3.87M
3
BETS
Bit Brother Limited Class A Ordinary Shares
BETS
+$2.24M
4
CNEY icon
CN Energy Group
CNEY
+$2.19M
5
NMTR
9 Meters Biopharma
NMTR
+$2.08M

Top Sells

Rank Stock Value
1
NVCT icon
Nuvectis Pharma
NVCT
+$4.41M
2
TBLT
ToughBuilt Industries, Inc. Common Stock
TBLT
+$2.28M
3
IWM icon
iShares Russell 2000 ETF
IWM
+$1.92M
4
BGXX
Bright Green Corporation Common Stock
BGXX
+$1.49M
5
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$1.34M

Sector Composition

Rank Sector Weight
1 Healthcare 9.81%
2 Technology 3.12%
3 Consumer Discretionary 2.1%
4 Communication Services 1.53%
5 Materials 1.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RVPH
51
PUT
DELISTED
REVIVA PHARMA HLDGS INC
RVPH
$134K 0.12%
16
– –
COCP icon
52
Cocrystal Pharma
COCP
$12.9M
$132K 0.11%
66,172
-354,538
-84% -$792K
COSM icon
53
Cosmos Holdings
COSM
$12.1M
$124K 0.11%
35,006
– –
RVPH
54
DELISTED
REVIVA PHARMA HLDGS INC
RVPH
$120K 0.1%
1,431
-294
-17% -$25.7K
BFRGW icon
55
Bullfrog AI Holdings Warrants
BFRGW
$155K
$113K 0.1%
+200,000
New +$133K
APDNW
56
PUT
DELISTED
Applied DNA Sciences Inc Warrant
APDNW
$100K 0.09%
885
-748
-46% -$84.5K
EDBL
57
Edible Garden
EDBL
$1.55M
– –
0
– –
GMBLZ
58
DELISTED
Esports Entertainment Group Inc. Warrant
GMBLZ
$91.7K 0.08%
4,631,800
-81,889
-2% -$1.88K
IONM
59
DELISTED
Assure Holdings Corp. Common Stock
IONM
$91.6K 0.08%
1,533
-425
-22% -$42.2K
CINGW icon
60
Cingulate Inc Warrants
CINGW
$59.3K
$91K 0.08%
606,765
-3,165
-0.5% -$736
MBAI
61
Check-Cap
MBAI
$8.12M
$90.6K 0.08%
+63,346
New +$190K
BEATW icon
62
Heartbeam Inc Warrant
BEATW
$57.8K
$88.9K 0.08%
181,514
-90,274
-33% -$71.5K
BNBX
63
DELISTED
BNB PLUS CORP
BNBX
$83.1K 0.07%
5
-5
-50% -$107K
BRSH
64
DELISTED
Bruush Oral Care Inc. Common Stock
BRSH
$82.1K 0.07%
+12,630
New +$121K
NCRA icon
65
Nocera
NCRA
$2.23M
$74.3K 0.06%
2,114
-2,873
-58% -$106K
MMAT
66
DELISTED
Meta Materials Inc. Common Stock
MMAT
$65.3K 0.06%
+1,603
New +$124K
CTRM icon
67
PUT
Castor Maritime
CTRM
$18.3M
$65.2K 0.06%
83
+1
+1% +$11
CTRM icon
68
Castor Maritime
CTRM
$18.3M
$64.7K 0.06%
8,189
+10
+0.1% +$110
LUCYW icon
69
Innovative Eyewear Inc Series A Warrants 8/16/27
LUCYW
$60.6K
$63.3K 0.06%
285,581
-89,292
-24% -$25K
BRSHW
70
DELISTED
Bruush Oral Care Inc. Warrant
BRSHW
$61.6K 0.05%
513,553
+121,344
+31% +$13.2K
GLBS icon
71
PUT
Globus Maritime Ltd
GLBS
$60.9M
$59.2K 0.05%
529
– –
OG
72
DELISTED
Onion Global Limited American Depositary Shares (each ten (10) ADSs representing one (1) Class A Ordinary Share)
OG
$50.4K 0.04%
1,200,489
– –
ATOS icon
73
Atossa Therapeutics
ATOS
$24.1M
$47.6K 0.04%
4,381
-9,217
-68% -$103K
RVPH
74
CALL
DELISTED
REVIVA PHARMA HLDGS INC
RVPH
$46.1K 0.04%
+6
New +$524
TANH icon
75
Tantech Holdings
TANH
$6.15M
$45.8K 0.04%
596
-442
-43% -$46.6K
1 2
3
4 5

Similar funds

CG
Circumference Group Little Rock, Arkansas $44.6M AUM 5.21% 1-Year Est. Return
OC
Optimas Capital Central, Hong Kong $44.5M AUM 24.43% 1-Year Est. Return
ICCON
Investment Counsel Company of Nevada Las Vegas, Nevada $44.5M AUM 21.97% 1-Year Est. Return
PCM
Prentice Capital Management Greenwich, Connecticut $45.7M AUM 2.65% 1-Year Est. Return
CAS
CTC Alternative Strategies Chicago, Illinois $44M AUM 43.15% 1-Year Est. Return
CM
Crestline Management Fort Worth, Texas $46.3M AUM 48.82% 1-Year Est. Return
MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return
CTC
Corundum Trust Company Sioux Falls, South Dakota $43.8M AUM 20.07% 1-Year Est. Return

Sabby Management's Q1 2023 Portfolio in Review

As of Q1 2023, Sabby Management held 142 positions worth $115M, up 0.69% from $114M the previous quarter. Its ten largest holdings account for 83% of the portfolio.

Sabby Management deployed $6.43M of net new capital in Q1 2023, opening 32 new positions and adding to 15 existing holdings. Its largest new stake was Recon Technology: 219,315 shares worth $1.35M.

By sector, the portfolio is most concentrated in Healthcare at 9.8% of assets, down from 16% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Cocrystal Pharma, an estimated $792K trimmed.

  • Sabby Management's largest Q1 2023 buy was Recon Technology: 219,315 shares worth $1.35M.
  • Sabby Management added most to Akari Therapeutics in Q1 2023, an estimated $1.68M increase.
  • Sabby Management's biggest Q1 2023 reduction was Cocrystal Pharma, cutting an estimated $792K.
  • Sabby Management fully exited Nuvectis Pharma in Q1 2023, selling an estimated $4.41M.
  • Sabby Management's ten largest holdings make up 83% of its $115M portfolio in Q1 2023.
  • Sabby Management opened 32 new positions and closed 53 in Q1 2023.
  • Sabby Management's portfolio value rose 0.69% quarter-over-quarter to $115M.

Based on Sabby Management's 13F filing for Q1 2023, filed 15 May 2023.